LINA KARAM to Humans
This is a "connection" page, showing publications LINA KARAM has written about Humans.
Connection Strength
0.075
-
NOD2 Polymorphisms May Direct a Crohn Disease Phenotype in Patients With Very Early-Onset Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2023 12 01; 77(6):748-752.
Score: 0.024
-
Disseminated tuberculosis in 2 children with inflammatory bowel disease receiving infliximab. Pediatr Infect Dis J. 2014 Jul; 33(7):779-81.
Score: 0.013
-
MYO5B and the Polygenic Landscape of Very Early-Onset Inflammatory Bowel Disease in an Ethnically Diverse Population. Inflamm Bowel Dis. 2025 01 06; 31(1):189-199.
Score: 0.007
-
Failure Rate of Anti-Tumor Necrosis Factor a Biologics in Very Early Onset Inflammatory Bowel Disease. Inflamm Bowel Dis. 2024 03 01; 30(3):510-512.
Score: 0.006
-
Infliximab Can Be Effective in Pediatric Patients with Ulcerative Colitis and Primary Failure of Adalimumab. Ann Clin Lab Sci. 2022 Sep; 52(5):796-801.
Score: 0.006
-
Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North America. J Pediatr Gastroenterol Nutr. 2022 07 01; 75(1):64-69.
Score: 0.006
-
High Seroconversion Rate Against Severe Acute Respiratory Syndrome Coronavirus 2 in Symptomatic Pediatric Inflammatory Bowel Disease Patients. J Pediatr Gastroenterol Nutr. 2021 09 01; 73(3):363-366.
Score: 0.005
-
Natural History of? Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. Inflamm Bowel Dis. 2021 02 16; 27(3):295-302.
Score: 0.005
-
Progression to colectomy in the era of biologics: A single center experience with pediatric ulcerative colitis. J Pediatr Surg. 2020 Sep; 55(9):1815-1823.
Score: 0.005